Purification of meningococcal group C polysaccharide by a procedure suitable for scale-up

Journal of Microbiological Methods

Volumn 27, Issue 1, 1996, Pages 19-23

  Tanizaki M, Martha ^a   Garcia, Ligiane R ^a   Ramos, Julia B ^a   Leite, Luciana C C ^a   Hiss, Haroldo ^a   Furuta, Joana A ^a   Cabrera Crespo, Joaquin ^a   Isaias, Raw ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Capsular polysaccharide; Neisseria meningitidis; Purification; Tangential ultrafiltration

Indexed keywords

ANTIGEN; BACTERIAL VACCINE; POLYSACCHARIDE;

ARTICLE; CONTROLLED STUDY; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; ULTRAFILTRATION;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS; ORYCTOLAGUS CUNICULUS;

EID: 0030250921     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-7012(96)00921-9     Document Type: Article

References (16)

1. [1] Farquhar, J.D., Hankins, W.A., Desanctis, A.N., Demeio, J.L. and Metzgar, D.P. (1977) Clinical and serological evaluation of purified polysaccharide vaccines prepared from Neisseria meningitidis group Y (39828). Proc. Soc. Exp. Biol. Med. 155, 453-455.
2. [2] Farquhar, J.D., Hankins, W.A., Desanctis, A.N., Demeio, A.N. and Metzgar, D.P. (1978) Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, and Y (39995). Proc. Soc. Exp. Biol. Med. 155, 79-82.
3. [3] Peltola, H.P., Makela, P.H., Kayhty, H., Jousimies, J., Herva, E., Hllstrom, K., Sivonen, O.V., Renkonen, O.V., Pettay, O., Karanko, V., Ahvonen, P. and Sarna, S. (1977) Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three mouths to five years of age. N. Engl. J. Med. 297, 686-691.
4. [4] Taunay, A.E., Galvão, P.A., Morais, J.S., Gotschlich, E.C. and Feldman, R.A. (1974) Disease prevention by meningococcal serougroup C. polysaccharide vaccine in preschool children: results after eleven mouths in São Paulo, Brazil. Pediatr. Res. 8, 429-235.
5. [5] Gotschlich, E.C., Liu, T.Y. and Artenstein, M.S. (1969) Human immunity to the meningococcus. J. Exp. Med. 129, 1349-1365.
6. [6] Ayne G., Donikian, R., Mynard, M.C. and Lagrandeur, G. (1973) Production and controls of serogroup A Neisseiria meningitidis polysaccharide vaccine. In: Table ronde ssur immunoprofilaxie de la meningite cerebro-spinale (Ed. R. Triav). Lyon Fondation Merieux., pp. 4-30.
7. [7] Svennerholm, L. (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys. Acta 241, 604-611.
8. [8] Lowry, O.H., Rosenbrough, N.J. and Farr, R H. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 165-275.
9. [9] Osborn, M.J. (1963) Studies on the gram negative cell wall. Evidence for the role of 2-keto-3-deoxyoctanate in the lipopolysaccharide of Salmonella typhimurium. Proc. Natl. Acad. Sci. 50, 499-506.
10. [10] Frasch, C.E. (1990) Production and control of Neisseria meningitidis vaccines. In: Bacterial vaccines (Ed. Alan R. Liss). Inc. New York, pp. 123-145.
11. [11] Frantz, I.D. Jr. (1942) Growth requirements of the meningococcus. J. Bacteriol. 43, 757-761.
12. [12] Ramos, J.B., Hiss, H., Vicentin, M.A., Paz, M.F., Peixoto, A., Leal, M.B.B., Gonçalves, P.C. and Raw, I. (1996) Batch cultivation kinetics of Neisseria meningitidis (Serogroup C) in Frantz medium. I. Growth and polysaccharide production. Arq. Biol. Tecnol. 39, 215-220.
13. [13] Wu, L., Tsai, C.M. and Frasch, C.E. (1987) A method for purification of bacterial R - type lipopolysaccharides (lipooligosaccharides). Anal. Biochem. 160, 281-289.
14. [14] Gu, X.X. and Tsai, C.M. (1991) Purification of rough type lipopolysaccharides of Neisseria meningitidis from cells and outer membrane vesicles in spent media. Anal. Biochem. 196, 311-318.
15. [15] Cheryan, M. (1986).Ultrafiltration applications. In: Ultrafiltration Handbook. (Ed. Alan S. Michaels). Technomic Publishing Co. Inc. Pennsylvania, pp. 231-340.
16. [16] Cryz, S.J., Furer, E. and Germanier, R. (1985). Purification and vaccine potential of Klebsiella capsular polysaccharides. Infect. Immun. 50, 225-230.